N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Effectiveness of Two Different Desensitizing Dental Varnishes

Sponsor: Ivoclar Vivadent AG • ClinicalTrials.gov ID: NCT07622043

Registry updated: 2026-08-20
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Dental varnishes are commonly used to relieve dentin hypersensitivity by forming a protective film that occludes dentinal tubules and reduces fluid flow. This clinical investigation aims to compare the desensitizing effect of a fluoride containing varnish with a fluoride free placebo varnish. Primary and secondary objectives include evaluating short and long term reductions in dentinal hypersensitivity, assessing patient reported outcomes and daily experiences, and monitoring the varnish's tolerability and safety.

Interventions

  • Fluoride-containing varnish (Device)
    A fluoride-containing varnish is applied to a tooth that is hypersensitive.
  • Fluoride-free varnish (Device)
    A fluoride-free varnish is applied to a tooth that is hypersensitive.

Eligibility criteria

Inclusion Criteria: * Informed Consent signed by the subject * Age: 18-65 years * Hypersensitivity assessment scale ≥ Grade 2 in * two non-neighboring teeth in different quadrants * The affected teeth are/have: vital, caries-free, received no restorations within the last month * No change in medication anticipated over the next 3 months (e.g. due to upcoming surgery etc.) Exclusion Criteria: * Contraindications and limitations of the MD as described in the instructions for use. * Known hypersensitivity or allergy to the device material (especially acrylates, mint flavouring) * Pregnant or other vulnerable subjects * Participants with severe systemic disease * Enrolment of employees of the dental clinic of Ivoclar Vivadent AG * Recent change in medication concerning Analgesics, NSAIDs, psychotropic drugs, other medications that may alter pain perception * Intake of analgesics prior to appointment * Professional desensitizing therapy in the last 3 months * Bleaching procedures in the last 4 weeks * Confounding dental conditions at test sites: defective or extensive restorations, abutment teeth for prostheses, recent restorations, pulpitis/periapical pathology. * Current or recent use of desensitizing toothpastes or mouthrinses (i.e. products specifically marketed for the treatment of dentin hypersensitivity) within 4 weeks prior to enrolment

Conditions

Dentin Hypersensitivity Dentin Desensitizing Agents

Locations

  • Internal Clinic Ivoclar Vivadent AG — Schaan, Liechtenstein
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record